Epacria Capital Partners »

Royalty Pharma shares owned by Epacria Capital Partners

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Epacria Capital Partners from 13F filings

Historical chart of Epacria Capital Partners investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Epacria Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Epacria Capital Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $400k 15k 26.37

More positions owned by Epacria Capital Partners

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Philip Morris International (PM)
British Amern Tob Sponsored Adr (BTI)
Black Stone Minerals Com Unit (BSM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Jefferies Finl Group (JEF)
Check Point Software Tech Lt Ord (CHKP)
Enterprise Products Partners (EPD)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Builders FirstSource (BLDR)
Sprouts Fmrs Mkt (SFM)
Interactive Brokers Group In Com Cl A (IBKR)
Canadian Natural Resources (CNQ)

View all positions for Epacria Capital Partners

Top funds holding Royalty Pharma

Morgan Stanley
Vanguard Group
BlackRock
BlackRock
Baillie Gifford & Co
Viking Global Investors
Swedbank AB
State Street Corporation
Geode Capital Management
Amundi
Siguler Guff Advisers
Charles Schwab Investment Management
Northern Trust
New South Capital Management
Deutsche Bank Aktiengesellschaft

View all funds holding Royalty Pharma